Related Experiment Video

Updated: Jan 2, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.1K

WT1/EGR1-mediated control of STIM1 expression and function in cancer cells

Michael F Ritchie1, Yandong Zhou, Jonathan Soboloff

  • 1Department of Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.

Frontiers in Bioscience (Landmark Edition)
|May 31, 2011
PubMed

Insights

Calcium (Ca2+) signaling is linked to cancer, with Wilms Tumor Suppressor 1 (WT1) and Early Growth Response 1 (EGR1) regulating STIM1. Aberrant Ca2+ homeostasis in cancers may offer therapeutic targets.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cellular Physiology

Background:

  • Numerous studies link calcium (Ca2+) signaling to cancer, but the precise mechanisms remain unclear.
  • The oncogenes/tumor suppressors Wilms Tumor Suppressor 1 (WT1) and Early Growth Response 1 (EGR1) are identified as regulators of STIM1 expression.
  • STIM1 is crucial for regulating Ca2+ entry in non-excitable cells.

Purpose of the Study:

  • To review the literature on differential Ca2+ signaling and WT1/EGR1 expression patterns in six specific cancer subtypes.
  • To assess how altered WT1 and EGR1 expression contributes to aberrant Ca2+ homeostasis in these cancers.
  • To explore the therapeutic potential of targeting these pathways.

Main Methods:

  • Literature review and analysis of existing publications.
  • Examination of Ca2+ signaling pathways.
  • Assessment of WT1 and EGR1 expression patterns in cancer.

Main Results:

  • Differential Ca2+ signaling and WT1/EGR1 expression are observed across Acute Myeloid Leukemia, Wilms Tumor, breast cancer, ovarian cancer, glioblastoma, and prostate cancer.
  • Specific alterations in WT1 and EGR1 expression correlate with aberrant Ca2+ homeostasis in these tumor types.
  • These findings suggest potential therapeutic strategies targeting Ca2+ signaling and WT1/EGR1.

Conclusions:

  • WT1 and EGR1 play significant roles in regulating Ca2+ homeostasis in various cancers.
  • Aberrant Ca2+ signaling due to altered WT1/EGR1 expression presents a potential therapeutic vulnerability.
  • Targeting these molecular pathways could offer novel treatment options for cancer patients.

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.9K
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.3K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.2K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.3K